...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!

Just to be clear narmac, I won't ever view Don as a hero even if the SP goes through the roof. 

However if Don and team come up with a brilliant, strategic deal that delivers shareholder value I will feel more positive. I don't think there is a chance that will happen. In my 11 years of holding and buying shares with this comapny I have never seen a hint of brilliance other than the science. On this busiiness side I've seen nothing but dilution, undervalued financings and SP erosion. Don does not have the education, network, vision nor drive to be qualified for the positions (COB, CEO, President) of both companies. He has failed to build business teams.

Anyway, we all know this and must live with it.

My hope is that the science will be so good that some BP will lay a good deal at the doorstep. Hopefully the BOD will recognize a good deal.

 GLTA

Toinv

Share
New Message
Please login to post a reply